UnknownNot Applicable

Anatomic Stenosis Severity as a Prognostic Marker in Patients With Low-Flow Low-Gradient Aortic Stenosis Undergoing TAVI

Canada, Denmark, France1,500 participantsStarted 2021-04-01

Plain-language summary

The ATLAS TAVI Registry is a retrospective, investigator-initiated, multicenter registry including patients, who underwent Transcatheter Aortic Valve Implantation (TAVI) for classical or paradoxical low-flow, low-gradient aortic stenosis (LFLG AS) with available non-contrast MSCT data on aortic valve calcification (AVC). The main objective of this study is the assessment of outcome after TAVI according to AVC density severity in patients with LFLG AS.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age ≥18 years * patient gave written informed consent for data acquisition and transfer * for LFLG AS: -- available non-contrast MSCT data on aortic valve calcification (AVC, Agatston Units) Exclusion Criteria: \- LFLG AS without non-contrast MSCT data on AVC

What they're measuring

All-cause mortality

Timeframe: 12 months

Trial details

NCT IDNCT04914481

SponsorUniversitätsklinikum Hamburg-Eppendorf

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

Contact for this trial

Niklas Schofer, MD

+49-40-7410-0 n.schofer@uke.de

View on ClinicalTrials.gov More Low-Flow, Low-Gradient Aortic Stenosis trials